Description
Overview
Overview
CD34 is a glycosylated transmembrane protein that serves as established marker of hematopoietic stem and progenitor cells. Umbilical Cord Blood (CB) is a rich source of CD34+ hematopoietic stem and progenitor cells (HSPCs), a rare and primitive population of multipotent cells that can give rise to all blood cell types.
Due to their superior proliferation, differentiation, and self-renewal, cord blood-derived CD34+ stem cells are an advantageous choice for a wide range of research including genome editing, immune regulation, hematopoiesis, and regenerative medicine.
Our CD34+ stem cells are derived from ethically sourced human umbilical cord blood collected using IRB protocols and/or in accordance with local, state and federal requirements. We use positive immunomagnetic techniques to isolate the cells resulting in a highly enriched population of CD34+ cells with exceptional viability.
What To Expect
> 95% Viability
> 90% Purity
Negative for HIV-1, HIV-2, Hepatitis B, Hepatitis C
Certificate of Analysis
Responsive Customer Support
Key Features
For Research Use Only
Various Cell Counts Available
Single and Pooled Donor Options
CD34+ cells frozen in 10% DMSO cryopreservation medium
Store in liquid nitrogen vapor phase
Cells Stable at < -135
o
C for one year from receipt
Available Cell Counts
750,000 Cells – Single Donor
1 Million Cells – Single Donor
2 Million Cells - Single Donor
2 Million Cells – Pooled Donor
Potential Research Applications
Molecular Genetics
Angiogenesis
Regenerative Medicine
Immune Diseases
Gene Editing/CRISPR
Validating Expansion Technology
Benefits of Using CD34+
CD34+ cells derived from umbilical cord blood (UCB) offer several advantages compared to those obtained from other sources of CD34+ cells, including:
Non-invasive collection
More Naïve/primitive than other sources
Greater proliferation
